Global Asthma & COPD Therapies Market Report 2023-2033: Expansion into Emerging Markets to Offer Lucrative Growth Opportunities
June 28, 2023 04:38 ET
|
Research and Markets
Dublin, June 28, 2023 (GLOBE NEWSWIRE) -- The "Asthma & COPD Therapies Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering.The Asthma & COPD Therapies Market...
DirectRx Takes the Lead in Lung Health for Patients Nationwide
June 07, 2023 06:23 ET
|
DirectRx Pharmacy
TROY, Mich., June 07, 2023 (GLOBE NEWSWIRE) -- DirectRx, a leading national specialty pharmacy dedicated to serving individual patients with complex and chronic health needs, has launched a new...
Noninvasive Ventilators and Airway Management Accessories Global Market Report 2023: Increasing Awareness Regarding the Health Benefits of CPAP Therapy Bolsters Sector
May 30, 2023 06:18 ET
|
Research and Markets
Dublin, May 30, 2023 (GLOBE NEWSWIRE) -- The "Noninvasive Ventilators and Airway Management Accessories" report has been added to ResearchAndMarkets.com's offering. The two most common...
Spexis provides business update and announces financial results for the full year 2022
May 30, 2023 01:15 ET
|
Spexis AG
Ad hoc announcement pursuant to Art. 53 LR USD 4.5 million capital commitment from SPRIM Global Investments to enable initiation of ColiFin® COPILOT study; first patient dosing expected in...
Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals
May 25, 2023 16:26 ET
|
Adamis Pharmaceuticals Corporation
DMK CEO, Ebrahim (Eboo) Versi, MD, PhD, named CEO and Chairman of the combined companyCombined company will have commercial products and a library of development candidates, including two clinical...
Adamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 15, 2023 16:47 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company focused on developing and commercializing products in...
Adamis Pharmaceuticals Schedules First Quarter 2023 Financial Results Conference Call and Corporate Update
May 08, 2023 16:05 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, May 08, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing...
Airway Management Devices Global Market Report 2023: Featuring Cardinal Health, Intersurgical, Medtronic, Dale Medical Products & More
April 21, 2023 05:03 ET
|
Research and Markets
Dublin, April 21, 2023 (GLOBE NEWSWIRE) -- The "Airway Management Devices: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for airway management...
Monaghan Medical and Premier Inc. Sign AscenDrive Contract
April 18, 2023 08:45 ET
|
Monaghan Medical Corporation
PLATTSBURGH, N.Y., April 18, 2023 (GLOBE NEWSWIRE) -- Monaghan Medical Corporation (Monaghan) and Premier, Inc., today announced their agreement to a three-year contract, effective May 1, 2023,...
Adamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update
March 16, 2023 16:24 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, March 16, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company focused on developing and commercializing products in various therapeutic...